Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease

Oncotarget

Volumn 5, Issue 18, 2014, Pages 8651-8664

  Hilton, Heidi N ^a   Doan, Tram B ^a   Dinny Graham, J ^a   Oakes, Samantha R ^b,c   Silvestri, Audrey ^a   Santucci, Nicole ^a   Kantimm, Silke ^a   Huschtscha, Lily I ^d   Ormandy, Christopher J ^b,c   Funder, John W ^e   Simpson, Evan R ^e   Kuczek, Elizabeth S ^a   Leedman, Peter J ^f   Tilley, Wayne D ^g   Fuller, Peter J ^e   Muscat, George E O ^h   Clarke, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

^e HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^g University of Adelaide   (Australia)

^h UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Breast cancer; Estrogen receptor; Human breast; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; MESSENGER RNA; TUMOR MARKER;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BREAST TUMOR; CASE CONTROL STUDY; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; INTRADUCTAL CARCINOMA; KAPLAN MEIER METHOD; MAMMARY GLAND; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SECONDARY; TIME; UDDER;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CASE-CONTROL STUDIES; CELL LINEAGE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KAPLAN-MEIER ESTIMATE; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; PROGNOSIS; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907997122     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2354     Document Type: Article

References (60)

1. Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res. 2002; 4(5):197-201.
2. Brisken C. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer. 2013; 13(6):385-396.
3. Fernandez SV and Russo J. Estrogen and xenoestrogens in breast cancer. Toxicol Pathol. 2010; 38(1):110-122.
4. Kelsey JL, Gammon MD and John EM. Reproductive factors and breast cancer. Epidemiol Rev. 1993; 15(1):36-47.
5. Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W, Stampfer MJ and Willett WC. Oral contraceptive use and breast cancer: A prospective study of young women. Cancer Epidemiol Biomarkers Prev. 2010; 19(10):2496-2502.
6. Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA and Prentice RL. Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study. J Natl Cancer Inst. 2013; 105(8):526-535.
7. Howard BA and Gusterson BA. Human breast development. J Mammary Gland Biol Neoplasia. 2000; 5(2):119-137.
8. Anderson E, Clarke R and Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia. 1998; 3(1):23-35.
9. Longacre TA and Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol. 1986; 10(6):382-393.
10. Hewitt SC, Harrell JC and Korach KS. Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol. 2005; 67(1):285-308.
11. Conneely OM, Mulac-Jericevic B, Lydon JP and De Mayo FJ. Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice. Mol Cell Endocrinol. 2001; 179(1-2):97-103.
12. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NS, Gazet JC, Nolan C and Coombes RC. Estrogen and progesterone receptors in the normal female breast. Cancer Res. 1991; 51(7):1817-1822.
13. Bartow SA. Use of the autopsy to study ontogeny and expression of the estrogen receptor gene in human breast. J Mammary Gland Biol Neoplasia. 1998; 3(1):37-48.
14. Shoker BS, Jarvis C, Sibson DR, Walker C and Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol. 1999; 188(3):237-244.
15. Belitskaya-Lévy I, Zeleniuch-Jacquotte A, Russo J, Russo IH, Bordás P, Åhman J, Afanasyeva Y, Johansson R, Lenner P, Li X, de Cicco RL, Peri S, Ross E, Russo PA, Santucci-Pereira J, Sheriff FS, et al. Characterization of a genomic signature of pregnancy identified in the breast. Cancer Prev Res (Phila). 2011; 4(9):1457-1464.
16. Asztalos S, Gann PH, Hayes MK, Nonn L, Beam CA, Dai Y, Wiley EL and Tonetti DA. Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila). 2010; 3(3):301-311.
17. Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH and Hawes D. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Res Treat. 2009; 118(1):161-168.
18. Meier-Abt F, Brinkhaus H and Bentires-Alj M. Early but not late pregnancy induces lifelong reductions in the proportion of mammary progesterone sensing cells and epithelial Wnt signaling. Breast Cancer Res. 2014; 16(2):402-405.
19. Graham JD, Mote PA, Salagame U, van Dijk JH, Balleine RL, Huschtscha LI, Reddel RR and Clarke CL. DNA replication licensing and progenitor numbers are increased by progesterone in normal human breast. Endocrinology. 2009; 150(7):3318-3326.
20. Hilton HN, Graham JD, Kantimm S, Santucci N, Cloosterman D, Huschtscha LI, Mote PA and Clarke CL. Progesterone and estrogen receptors segregate into different cell subpopulations in the normal human breast. Mol Cell Endocrinol. 2012; 361(1-2):191-201.
21. Osborne CK, Schiff R, Arpino G, Lee AS and Hilsenbeck VG. Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy. Breast. 2005; 14(6):458-465.
22. Tran B and Bedard P. Luminal-B breast cancer and novel therapeutic targets. Breast Cancer Res. 2011; 13(6):221-230.
23. Brisken C and O'Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010; 2(12):a003178.
24. Nelson JF, Felicio LS, Osterburg HH and Finch CE. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6J mice. Biol Reprod. 1981; 24:784-794.
25. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW and Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci USA. 1998; 95(9):5076-5081.
26. Mallepell S, Krust A, Chambon P and Brisken C. Paracrine signaling through the epithelial estrogen receptor a is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci USA. 2006; 103(7):2196-2201.
27. Zeps N, Bentel JM, Papadimitriou JM and Dawkins HJS. Murine progesterone receptor expression in proliferating mammary epithelial cells during normal pubertal development and adult estrous cycle: Association with ERa and ERβ status. J Histochem Cytochem. 1999; 47(10):1323-1330.
28. Aupperlee MD and Haslam SZ. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland. Endocrinology. 2007; 148(5):2290-2300.
29. Hilton HN, Santucci N, Silvestri A, Kantimm S, Huschtscha LI, Graham JD and Clarke CL. Progesterone stimulates progenitor cells in normal human breast and breast cancer cells. Breast Cancer Res Treat. 2014;143(3):423-33.
30. Bachelard-Cascales E, Chapellier M, Delay E, Pochon G, Voeltzel T, Puisieux A, Caron de Fromentel C and Maguer-Satta V. The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells. 2010; 28(6):1081-1088.
31. Garbe JC, Pepin F, Pelissier FA, Sputova K, Fridriksdottir AJ, Guo DE, Villadsen R, Park M, Petersen OW, Borowsky AD, Stampfer MR and LaBarge MA. Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res. 2012; 72(14):3687-3701.
32. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, Smith AE, Prat A, Perou CM, Gilmore H, Schnitt S, Naber SP, Garlick JA and Kuperwasser C. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci USA. 2012; 109(8):2772-2777.
33. Stingl J, Eaves CJ, Kuusk U and Emerman JT. Phenotypic and functional characterization in vitro of a multipotent epithelial cell present in the normal adult human breast. Differentiation. 1998; 63(4):201-213.
34. Hilton HN, Kantimm S, Graham JD and Clarke CL. Changed lineage composition is an early event in breast carcinogenesis. Histol Histopathol. 2013; 28(9):1197-1204.
35. Muscat GEO, Eriksson NA, Byth K, Loi S, Graham D, Jindal S, Davis MJ, Clyne C, Funder JW, Simpson ER, Ragan MA, Kuczek E, Fuller PJ, Tilley WD, Leedman PJ and Clarke CL. Research resource: Nuclear receptors as transcriptome: Discriminant and prognostic value in breast cancer. Mol Endocrinol. 2013; 27(2):350-365.
36. Wilson CL, Sims AH, Howell A, Miller CJ and Clarke RB. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer. 2006; 13(2):617-628.
37. Mohan HM, Aherne CM, Rogers AC, Baird AW, Winter DC and Murphy EP. Molecular pathways: The role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res. 2012; 18(12):3223-3228.
38. Nautiyal J, Steel JH, Mane MR, Oduwole O, Poliandri A, Alexi X, Wood N, Poutanen M, Zwart W, Stingl J and Parker MG. The transcriptional co-factor RIP140 regulates mammary gland development by promoting the generation of key mitogenic signals. Development. 2013; 140(5):1079-1089.
39. Clarke CL and Graham JD. Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes. PLoS oNE. 2012; 7(4):e35859.
40. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012; 486(7403):346-352.
41. Sim E, Abuhammad A and Ryan A. Arylamine N-acetyltransferases: From drug metabolism and Pharmacogenetics to drug discovery. Br J Pharmacol. 2014:171(11):2705-25.
42. Budczies J, Brockmöller SF, Müller BM, Barupal DK, Richter-Ehrenstein C, Kleine-Tebbe A, Griffin JL, Orešic M, Dietel M, Denkert C and Fiehn O. Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism. J Proteomics. 2013; 94:279-288.
43. Boulos FI, Dupont WD, Simpson JF, Schuyler PA, Sanders ME, Freudenthal ME and Page DL. Histologic associations and long-term cancer risk in columnar cell lesions of the breast. Cancer. 2008; 113(9):2415-2421.
44. Cichon M, Degnim A, Visscher D and Radisky D. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer. J Mammary Gland Biol Neoplasia. 2010; 15(4):389-397.
45. Itoh M, Iwamoto T, Matsuoka J, Nogami T, Motoki T, Shien T, Taira N, Niikura N, Hayashi N, Ohtani S, Higaki K, Fujiwara T, Doihara H, Symmans WF and Pusztai L. Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers. Breast Cancer Res Treat. 2014; 143(2):403-409.
46. Yang X, Figueroa J, Hewitt S, Falk R, Pfeiffer R, Lissowska J, Peplonska B, Brinton L, Garcia-Closas M and Sherman M. Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer. Breast Cancer Res Treat. 2013; 137(3):837-847.
47. Ström A, Hartman J, Foster JS, Kietz S, Wimalasena J and Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA. 2004; 101(6):1566-1571.
48. Fillmore CM, Gupta PB, Rudnick JA, Caballero S, Keller PJ, Lander ES and Kuperwasser C. Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling. Proc Natl Acad Sci USA. 2010; 107(50):21737-21742.
49. Axlund S, Yoo B, Rosen R, Schaack J, Kabos P, LaBarbera D and Sartorius C. Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties. Horm Cancer. 2013; 4(1):36-49.
50. Horwitz KB and Sartorius CA. Progestins in hormone replacement therapies reactivate cancer stem cells in women with preexisting breast cancers: a hypothesis. J Clin Endocrinol Metab. 2008; 93(9):3295-3298.
51. Simões B, Piva M, Iriondo O, Comaills V, López-Ruiz J, Zabalza I, Mieza J, Acinas O and Vivanco MM. Effects of estrogen on the proportion of stem cells in the breast. Breast Cancer Res Treat. 2011; 129(1):23-35.
52. Visvader JE. Cells of origin in cancer. Nature. 2011; 469(7330):314-322.
53. Chan P, Moller A, Liu M, Sceneay J, Wong C, Waddell N, Huang K, Dobrovic A, Millar E, O'Toole S, McNeil C, Sutherland R, Bowtell D and Fox S. The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expression. Breast Cancer Res. 2011; 13(1):R19.
54. Andres S, Brock G and Wittliff J. Interrogating differences in expression of targeted gene sets to predict breast cancer outcome. BMC Cancer. 2013; 13(1):326.
55. Gatenby RA and Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004; 4(11):891-899.
56. Graham JD, Mote PA, Salagame U, Balleine RL, Huschtscha LI and Clarke CL. Hormone-responsive model of primary human breast epithelium. J Mammary Gland Biol Neoplasia. 2009; 14(4):367-379.
57. Mote PA, Leary JA and Clarke CL. Immunohistochemical detection of progesterone receptors in archival breast cancer. Biotech Histochem. 1998; 73(3):117-127.
58. Mote PA, Balleine RL, McGowan EM and Clarke CL. Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle. J Clin Endocrinol Metab 1999; 84(8):2963-2971.
59. Schmidt D, Schwalie PC, Ross-Innes CS, Hurtado A, Brown GD, Carroll JS, Flicek P and Odom DT. A CTCF-independent role for cohesin in tissue-specific transcription. Genome Res. 2010; 20(5):578-588.
60. Zhang Y, Liu T, Meyer C, Eeckhoute J, Johnson D, Bernstein B, Nusbaum C, Myers R, Brown M, Li W and Liu XS. Model-based analysis of ChIP-Seq (MACS). Genome Biology. 2008; 9(9):R137.